Stoke Therapeutics
STOK
STOK
148 hedge funds and large institutions have $1.57B invested in Stoke Therapeutics in 2025 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 46 increasing their positions, 42 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
11% more funds holding
Funds holding: 133 → 148 (+15)
3.48% more ownership
Funds ownership: 120.06% → 123.54% (+3.5%)
10% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 42
Holders
148
Holding in Top 10
5
Calls
$13.4M
Puts
$2.44M
Top Buyers
| 1 | +$38.9M | |
| 2 | +$30.7M | |
| 3 | +$18.1M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$14.1M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$10.3M |
Top Sellers
| 1 | -$36M | |
| 2 | -$23.5M | |
| 3 | -$12.9M | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$7.81M |
| 5 |
Corient Private Wealth
Miami,
Florida
|
-$7.49M |
